Dr. Wulf Dröge, Ph.D.

Dr. Wulf Dröge is actively engaged in the design of clinical studies and organizes research activities in cooperation with colleagues at McGill University and other leading scientific institutions.

After his doctorate at the University of Freiburg, Dr. Dröge conducted research at the Max-Planck Institute of Immunobiology in Freiburg, Germany, and the University of Minnesota, with renowned immunologist Dr. R.A. Good. Afterwards, he served for three years as a research fellow at Harvard University and for four years as a scientific member at the world-renowned Basel Institute for Immunology.

What followed was an almost 30 year career as a professor of immunology and cell biology at the University of Heidelberg and head of the Department of Immunochemistry at the National Cancer Center of Germany (Deutsches Krebsforschungszentrum). His international reputation in the field of redox physiology and aging research is based on more than 260 publications in international scientific journals. His research has been focused on the areas of redox regulation and signaling pathways, pathogenesis of HIV infection, the mechanisms of disease-related wasting and aging, and the action of tumor necrosis factor.

A world-renowned research scientist, Dr. Dröge has devoted more than forty years to basic and clinical research that form the basis for the design of safe, effective new Immunotec products.

He has earned postdoctoral fellowships at the Max-Planck Institute and Harvard University and continues to write articles in the field of redox physiology, cancer and aging research and an adjunct professor at McGill University.